BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3000299)

  • 21. [Phase I study of an oral administration of VP 16-213].
    Ogawa M; Ota K; Oyama A; Fukuoka M; Takada M; Yoshida S; Sanpi K; Kimura I; Ohnoshi T; Kuraishi Y
    Gan To Kagaku Ryoho; 1983 Nov; 10(11):2403-7. PubMed ID: 6639102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Etoposide and cisplatin salvage chemotherapy for small cell lung cancer.
    Lopez JA; Mann J; Grapski RT; Nassif E; Vannicola P; Krikorian JG; Finkel H
    Cancer Treat Rep; 1985 Apr; 69(4):369-71. PubMed ID: 2986833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Phase I clinical study of 21-consecutive-day oral administration of etoposide].
    Noda K; Fukuoka M; Komatsu H; Hayashihara K; Ariyoshi Y; Tanaka K; Nakajima H; Terashima Y; Nagao K; Furuse K
    Gan To Kagaku Ryoho; 1994 Aug; 21(10):1633-9. PubMed ID: 8060139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [An elderly case of small cell lung cancer showing a good partial response by chronic daily administration of oral etoposide].
    Ishikawa S; Shimizu E; Kawaji K; Mukai J; Tani K; Okubo A; Ogura T; Sano T; Yamashita T
    Gan To Kagaku Ryoho; 1991 Jan; 18(1):111-4. PubMed ID: 1846280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A phase I study of cisplatin, etoposide, and paclitaxel in small cell lung cancer: a University of Colorado Cancer Center study.
    Bunn PA; Kelly KL
    Semin Oncol; 1995 Oct; 22(5 Suppl 12):54-8; discussion 59-60. PubMed ID: 7481862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Phase II study of etoposide (VP-16-213) in genitourinary tumors. VP-16-213 Genitourinary Study Group].
    Suzuki K
    Gan To Kagaku Ryoho; 1986 Sep; 13(9):2772-9. PubMed ID: 3753024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Response rate and toxicity of etoposide (VP-16) in squamous carcinoma of the lung: report from the Lung Cancer Treatment Study Group.
    Anderson G; Payne H
    Semin Oncol; 1985 Mar; 12(1 Suppl 2):21-2. PubMed ID: 3883504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pilot study of dose intensive weekly chemotherapy followed by cisplatin plus etoposide with concurrent thoracic irradiation for limited-disease small-cell lung cancer. West Japan Thoracic Oncology Group].
    Isobe T; Fukuoka M; Negoro S; Sugiura T; Kawahara M; Kudoh S; Araki J; Nakagawa K; Yokozaki M; Yamakido M; Ariyoshi Y
    Gan To Kagaku Ryoho; 2000 Jul; 27(8):1091-6. PubMed ID: 10945001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preliminary study of efficacy of intravenous cisplatin plus oral etoposide in small cell lung cancer.
    Chewaskulyong B; Thongprasert S
    J Med Assoc Thai; 1998 Jan; 81(1):37-41. PubMed ID: 9470320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Early phase II trial of oral etoposide administered for 21 consecutive days in patients with cervical or ovarian cancer. ETP 21 Study Group--Cervical-Ovarian Cancer Group].
    Noda K; Tanaka K; Ozaki M; Hirabayasi K; Hasegawa K; Nishiya I; Yakushiji M; Izumi R; Tomoda Y; Ogita Y; Sugimori H; Yamabe T; Kudo R; Yajima A; Terashima Y; Fujii S; Suzuoki Y; Okada H; Kono I; Ochiai K; Yamamoto T; Ikeda M; Umesaki N; Saito T; Niitani H
    Gan To Kagaku Ryoho; 1998 Nov; 25(13):2061-8. PubMed ID: 9838908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-dose etoposide therapy for extensive small cell lung cancer: a Cancer and Leukemia Group B Study.
    Luikart SD; Propert KJ; Modeas CR; Green MR; Perry MC
    Cancer Treat Rep; 1987 May; 71(5):533-4. PubMed ID: 3032434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase I and pharmacologic study of sequential topotecan-carboplatin-etoposide in patients with extensive stage small cell lung cancer.
    Miller AA; Al Omari A; Murry DJ; Case D
    Lung Cancer; 2006 Dec; 54(3):379-85. PubMed ID: 17049403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Etoposide infusions for treatment of metastatic lung cancer.
    Steward WP; Thatcher N; Edmundson JM; Shiu W; Wilkinson PM
    Cancer Treat Rep; 1984 Jun; 68(6):897-9. PubMed ID: 6329509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
    Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cisplatin and etoposide alternating ifosfamide, vincristine, epirubicin in small cell lung cancer.
    Unsal M; Erturk D
    Saudi Med J; 2003 Jun; 24(6):628-31. PubMed ID: 12847592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group.
    Ariyoshi Y; Fukuoka M; Furuse K; Saijo N; Ikegami H; Nishiwaki Y; Tamura T; Shimoyama M; Suemasu K
    Jpn J Clin Oncol; 1994 Oct; 24(5):275-81. PubMed ID: 7967106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.
    Rose PG; Blessing JA; Van Le L; Waggoner S
    Gynecol Oncol; 1998 Aug; 70(2):263-6. PubMed ID: 9740702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Phase II study of a continuous five-day intravenous infusion of cisplatin and etoposide with concurrent chest radiation therapy in limited stage small cell lung cancer].
    Sugita T; Matsunaga K; Kobayashi H; Horikawa S; Suzuki Y; Nishiyama H; Maekawa N; Matsumoto H; Okazaki M; Katagami N
    Gan To Kagaku Ryoho; 1994 Oct; 21(14):2479-83. PubMed ID: 7944494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A combination chemotherapy of cisplatin and etoposide in small cell lung cancer].
    Honda R; Nishiwaki Y; Hino M; Hayashibe A; Yano H; Kitaya T; Matsuyama T
    Gan To Kagaku Ryoho; 1986 Oct; 13(10):2965-9. PubMed ID: 3021067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A phase I study of ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer.
    Strauss GM; Lynch TJ; Elias AD; Jacobs C; Kwiatkowski DJ; Shulman LN; Carey RW; Grossbard ML; Jauss S; Sugarbaker DJ
    Semin Oncol; 1995 Aug; 22(4 Suppl 9):70-4. PubMed ID: 7544029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.